These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones. Martín-Encinas E; Rubiales G; Knudssen BR; Palacios F; Alonso C Eur J Med Chem; 2019 Sep; 178():752-766. PubMed ID: 31229877 [TBL] [Abstract][Full Text] [Related]
6. Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors. Arepalli SK; Lee C; Sim S; Lee K; Jo H; Jun KY; Kwon Y; Kang JS; Jung JK; Lee H Bioorg Med Chem; 2018 Oct; 26(18):5181-5193. PubMed ID: 30253887 [TBL] [Abstract][Full Text] [Related]
7. A Convenient Method for the Synthesis of Chromeno[4,3-b]pyridines Via Three-component Reaction. Nikookar H; Moghimi S; Sayahi MH; Mahdavi M; Ranjbar PR; Firoozpour L; Foroumadi A Comb Chem High Throughput Screen; 2018; 21(5):344-348. PubMed ID: 29792140 [TBL] [Abstract][Full Text] [Related]
8. DBU-Mediated Domino Annulation Reaction of 2-Amino-4 Li H; Xin J; Xue Y; Wang C J Org Chem; 2022 Sep; 87(17):11857-11864. PubMed ID: 35960790 [TBL] [Abstract][Full Text] [Related]
11. Pot, atom and step economic (PASE) assembly of salicylaldehydes, malononitrile dimer and 4-hydroxypyridine-2(1H)-ones into medicinally relevant 5H-chromeno[2,3-b]pyridine scaffold. Elinson MN; Vereshchagin AN; Anisina YE; Krymov SK; Fakhrutdinov AN; Goloveshkin AS; Egorov MP Mol Divers; 2020 Aug; 24(3):617-626. PubMed ID: 31177361 [TBL] [Abstract][Full Text] [Related]
12. Piperidine-Mediated [3 + 3] Cyclization of 2-Amino-4 Zhang D; Luo N; Gan J; Wan X; Wang C J Org Chem; 2021 Jul; 86(13):9218-9224. PubMed ID: 34161098 [TBL] [Abstract][Full Text] [Related]
13. Novel synthesis of 7-fluoro-8-(trifluoromethyl)- 1H-1,6-naphthyridin-4-one derivatives: intermolecular cyclization of an N-silyl-1-azaallyl anion with perfluoroalkene and subsequent intramolecular skeletal transformation of the resulting pentasubstituted pyridines. Suzuki H; Sakai N; Iwahara R; Fujiwaka T; Satoh M; Kakehi A; Konakahara T J Org Chem; 2007 Jul; 72(15):5878-81. PubMed ID: 17602590 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and characteristics of novel fluorescence dyes based on chromeno[4,3,2-de][1,6]naphthyridine framework. Wang H; Shi J; Wang C; Zhang X; Zhao L; Wan Y; Wu H Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 103():62-7. PubMed ID: 23257331 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions. Kardile RA; Sarkate AP; Borude AS; Mane RS; Lokwani DK; Tiwari SV; Azad R; Burra PVLS; Thopate SR Bioorg Chem; 2021 Oct; 115():105174. PubMed ID: 34314913 [TBL] [Abstract][Full Text] [Related]
16. Efficient synthesis and evaluation of antitumor activities of novel functionalized 1,8-naphthyridine derivatives. Fu L; Feng X; Wang JJ; Xun Z; Hu JD; Zhang JJ; Zhao YW; Huang ZB; Shi DQ ACS Comb Sci; 2015 Jan; 17(1):24-31. PubMed ID: 25412896 [TBL] [Abstract][Full Text] [Related]
20. Silica gel-catalyzed one-pot syntheses in water and fluorescence properties studies of 5-amino-2-aryl-3H-chromeno[4,3,2-de][1,6]naphthyridine-4-carbonitriles and 5-amino-2-aryl-3H-quinolino[4,3,2-de][1,6]naphthyridine-4-carbonitriles. Wu H; Lin W; Wan Y; Xin HQ; Shi DQ; Shi YH; Yuan R; Bo RC; Yin W J Comb Chem; 2010; 12(1):31-4. PubMed ID: 20025233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]